The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Recombinant Proteins Market Research Report 2025
Synopsis
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
The global Recombinant Proteins market was valued at US$ 975.8 million in 2023 and is anticipated to reach US$ 2320.6 million by 2030, witnessing a CAGR of 13.0% during the forecast period 2024-2030.
Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.
This report aims to provide a comprehensive presentation of the global market for Recombinant Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Proteins.
Report Scope
The Recombinant Proteins market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Proteins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Proteins companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto
Segment by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Proteins companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
The global Recombinant Proteins market was valued at US$ 975.8 million in 2023 and is anticipated to reach US$ 2320.6 million by 2030, witnessing a CAGR of 13.0% during the forecast period 2024-2030.
Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.
This report aims to provide a comprehensive presentation of the global market for Recombinant Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Proteins.
Report Scope
The Recombinant Proteins market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Proteins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Proteins companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto
Segment by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Proteins companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Proteins Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hormones
1.2.3 Growth Factors
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinant Metabolic Enzymes
1.2.7 Immune Checkpoint Regulators
1.2.8 Others
1.3 Market by Application
1.3.1 Global Recombinant Proteins Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Proteins Market Perspective (2019-2030)
2.2 Recombinant Proteins Growth Trends by Region
2.2.1 Global Recombinant Proteins Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Recombinant Proteins Historic Market Size by Region (2019-2024)
2.2.3 Recombinant Proteins Forecasted Market Size by Region (2025-2030)
2.3 Recombinant Proteins Market Dynamics
2.3.1 Recombinant Proteins Industry Trends
2.3.2 Recombinant Proteins Market Drivers
2.3.3 Recombinant Proteins Market Challenges
2.3.4 Recombinant Proteins Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Proteins Players by Revenue
3.1.1 Global Top Recombinant Proteins Players by Revenue (2019-2024)
3.1.2 Global Recombinant Proteins Revenue Market Share by Players (2019-2024)
3.2 Global Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant Proteins Revenue
3.4 Global Recombinant Proteins Market Concentration Ratio
3.4.1 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Proteins Revenue in 2023
3.5 Recombinant Proteins Key Players Head office and Area Served
3.6 Key Players Recombinant Proteins Product Solution and Service
3.7 Date of Enter into Recombinant Proteins Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Proteins Breakdown Data by Type
4.1 Global Recombinant Proteins Historic Market Size by Type (2019-2024)
4.2 Global Recombinant Proteins Forecasted Market Size by Type (2025-2030)
5 Recombinant Proteins Breakdown Data by Application
5.1 Global Recombinant Proteins Historic Market Size by Application (2019-2024)
5.2 Global Recombinant Proteins Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Recombinant Proteins Market Size (2019-2030)
6.2 North America Recombinant Proteins Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Recombinant Proteins Market Size by Country (2019-2024)
6.4 North America Recombinant Proteins Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Proteins Market Size (2019-2030)
7.2 Europe Recombinant Proteins Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Recombinant Proteins Market Size by Country (2019-2024)
7.4 Europe Recombinant Proteins Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Proteins Market Size (2019-2030)
8.2 Asia-Pacific Recombinant Proteins Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Recombinant Proteins Market Size by Region (2019-2024)
8.4 Asia-Pacific Recombinant Proteins Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Proteins Market Size (2019-2030)
9.2 Latin America Recombinant Proteins Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Recombinant Proteins Market Size by Country (2019-2024)
9.4 Latin America Recombinant Proteins Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Proteins Market Size (2019-2030)
10.2 Middle East & Africa Recombinant Proteins Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Recombinant Proteins Market Size by Country (2019-2024)
10.4 Middle East & Africa Recombinant Proteins Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Techne Corporation
11.1.1 Bio-Techne Corporation Company Detail
11.1.2 Bio-Techne Corporation Business Overview
11.1.3 Bio-Techne Corporation Recombinant Proteins Introduction
11.1.4 Bio-Techne Corporation Revenue in Recombinant Proteins Business (2019-2024)
11.1.5 Bio-Techne Corporation Recent Development
11.2 Abcam PLC
11.2.1 Abcam PLC Company Detail
11.2.2 Abcam PLC Business Overview
11.2.3 Abcam PLC Recombinant Proteins Introduction
11.2.4 Abcam PLC Revenue in Recombinant Proteins Business (2019-2024)
11.2.5 Abcam PLC Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Recombinant Proteins Introduction
11.3.4 Merck KGaA Revenue in Recombinant Proteins Business (2019-2024)
11.3.5 Merck KGaA Recent Development
11.4 Miltenyi Biotec
11.4.1 Miltenyi Biotec Company Detail
11.4.2 Miltenyi Biotec Business Overview
11.4.3 Miltenyi Biotec Recombinant Proteins Introduction
11.4.4 Miltenyi Biotec Revenue in Recombinant Proteins Business (2019-2024)
11.4.5 Miltenyi Biotec Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Recombinant Proteins Introduction
11.5.4 Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 ACROBiosystems
11.6.1 ACROBiosystems Company Detail
11.6.2 ACROBiosystems Business Overview
11.6.3 ACROBiosystems Recombinant Proteins Introduction
11.6.4 ACROBiosystems Revenue in Recombinant Proteins Business (2019-2024)
11.6.5 ACROBiosystems Recent Development
11.7 Sino Biological
11.7.1 Sino Biological Company Detail
11.7.2 Sino Biological Business Overview
11.7.3 Sino Biological Recombinant Proteins Introduction
11.7.4 Sino Biological Revenue in Recombinant Proteins Business (2019-2024)
11.7.5 Sino Biological Recent Development
11.8 Cytiva
11.8.1 Cytiva Company Detail
11.8.2 Cytiva Business Overview
11.8.3 Cytiva Recombinant Proteins Introduction
11.8.4 Cytiva Revenue in Recombinant Proteins Business (2019-2024)
11.8.5 Cytiva Recent Development
11.9 Eurogentec
11.9.1 Eurogentec Company Detail
11.9.2 Eurogentec Business Overview
11.9.3 Eurogentec Recombinant Proteins Introduction
11.9.4 Eurogentec Revenue in Recombinant Proteins Business (2019-2024)
11.9.5 Eurogentec Recent Development
11.10 GenScript Biotech Corporation
11.10.1 GenScript Biotech Corporation Company Detail
11.10.2 GenScript Biotech Corporation Business Overview
11.10.3 GenScript Biotech Corporation Recombinant Proteins Introduction
11.10.4 GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2019-2024)
11.10.5 GenScript Biotech Corporation Recent Development
11.11 Reprocell
11.11.1 Reprocell Company Detail
11.11.2 Reprocell Business Overview
11.11.3 Reprocell Recombinant Proteins Introduction
11.11.4 Reprocell Revenue in Recombinant Proteins Business (2019-2024)
11.11.5 Reprocell Recent Development
11.12 BPS Bioscience
11.12.1 BPS Bioscience Company Detail
11.12.2 BPS Bioscience Business Overview
11.12.3 BPS Bioscience Recombinant Proteins Introduction
11.12.4 BPS Bioscience Revenue in Recombinant Proteins Business (2019-2024)
11.12.5 BPS Bioscience Recent Development
11.13 Abnova Corporation
11.13.1 Abnova Corporation Company Detail
11.13.2 Abnova Corporation Business Overview
11.13.3 Abnova Corporation Recombinant Proteins Introduction
11.13.4 Abnova Corporation Revenue in Recombinant Proteins Business (2019-2024)
11.13.5 Abnova Corporation Recent Development
11.14 ProSpec Tany TechnoGene
11.14.1 ProSpec Tany TechnoGene Company Detail
11.14.2 ProSpec Tany TechnoGene Business Overview
11.14.3 ProSpec Tany TechnoGene Recombinant Proteins Introduction
11.14.4 ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2019-2024)
11.14.5 ProSpec Tany TechnoGene Recent Development
11.15 Ajinomoto
11.15.1 Ajinomoto Company Detail
11.15.2 Ajinomoto Business Overview
11.15.3 Ajinomoto Recombinant Proteins Introduction
11.15.4 Ajinomoto Revenue in Recombinant Proteins Business (2019-2024)
11.15.5 Ajinomoto Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
